Do soy foods lower cholesterol and ease menopause symptoms?
Soy protein trims LDL cholesterol by a few points. For hot flashes, some trials show a small help and others find nothing.
Published October 2026
Short answer
Soy protein lowers LDL cholesterol by a small amount. For hot flashes, the evidence is mixed and limited. Evidence grade C (Limited). Meta-analyses of randomised trials; downgraded for inconsistent results and because LDL is a surrogate marker.
Key takeaways
- Pooled trials show soy protein lowers LDL ('bad') cholesterol by about 5 mg/dL, roughly 3 to 4 per cent [1][2].
- Isolated soy isoflavone supplements did not change the lipid profile in one meta-analysis, so soy protein looks like the active part [2][3].
- For hot flashes, one meta-analysis found about 0.8 fewer a day, but the Cochrane review found no conclusive benefit [4][5].
- A six-month trial of 270 women found no significant change in menopause symptoms from soy flour or daidzein [6].
- A study of more than 300,000 Chinese women found moderate soy intake was not linked to breast cancer risk [7].
The short version
Soy protein lowers "bad" LDL cholesterol by a small amount, about 5 mg/dL in pooled trials [1][2]. For hot flashes and other menopause symptoms, the evidence is mixed and limited. Some reviews find a modest drop in hot flashes, but a Cochrane review found no conclusive benefit [4][5].
What the studies show
For cholesterol, a pooled analysis of 46 trials that the US Food and Drug Administration (FDA) reviewed for its soy heart-health claim found that soy protein, at a median of 25 g a day for about six weeks, lowered LDL by about 4.8 mg/dL [1]. A separate analysis of 35 trials found a similar drop, and a bigger one in people with high cholesterol [2]. A cumulative analysis of those same 46 trials found the LDL drop stayed statistically significant in every year after the FDA's 1999 claim [8].
For menopause, one analysis of 16 soy isoflavone trials, about 1,710 women, estimated that isoflavones cut hot flashes by about 25% once the placebo effect was removed. It also found the effect is slow, taking about 13 weeks to reach half its strength and at least 48 weeks to reach 80% of it [9]. A 2016 analysis of 62 trials of plant-based therapies linked soy isoflavones to about 0.8 fewer hot flashes a day [4]. In a trial of 90 women, hot flush frequency fell by about 44% to 49% on soy germ isoflavone doses, compared with about 28% on placebo [10].
Not every trial agrees. A six-month trial of 270 women given 40 g of soy flour a day or a soy compound called daidzein found no significant change in symptoms compared with placebo [6]. A Cochrane review of 43 trials with 4,364 women found no conclusive evidence that phytoestrogen foods or supplements reduce hot flushes or night sweats [5].
The nuances
Soy protein seems to matter more than isoflavone pills. Isolated soy protein lowered LDL more than isolated isoflavones in a meta-analysis of postmenopausal women [3]. Isoflavone supplements alone had no effect on the lipid profile in another meta-analysis [2].
The cholesterol effect is less certain after menopause. In a 2021 meta-analysis of 2,305 postmenopausal women, total cholesterol fell by about 4.6 mg/dL, but the LDL drop of about 1.9 mg/dL was not statistically significant [11].
Results vary a lot between trials. One 2015 analysis reported heterogeneity (a measure of how much the trials disagree) of 92 to 99% [2].
Many menopause trials were small and at high risk of bias, and placebo groups improved by between 1% and 59% [5][4]. Some products mix soy with other herbs such as black cohosh or hops, so their results do not show what soy alone does [12][13].
Mood is a mixed picture. A 2019 trial of 101 women found a soy drink had no effect on everyday mood [14]. A 2024 meta-analysis of five trials found a small drop in depression but no effect on overall menopause symptoms, and its authors warned that many included trials carried a high risk of conflict of interest [15].
Breast cancer: a study of more than 300,000 Chinese women found moderate soy intake was not linked to breast cancer risk [7]. In women already diagnosed, soy intake before diagnosis was linked to a small reduction in overall survival after menopause, but the evidence is limited [16].
Thyroid: in a 60-person trial of people with mild underactive thyroid, a high dose of 16 mg of soy phytoestrogens a day was followed by overt hypothyroidism in six people [17]. A small study of 12 women taking levothyroxine found a soy isoflavone supplement did not change how well the medicine was absorbed [18]. A review concluded that any such effect seems to have little clinical impact [19].
What this means for you
The LDL trials used a median of 25 g of soy protein a day [1]. Expect a small change: about 5 mg/dL in trials. Discuss your cholesterol plan with a doctor, who can weigh that against your overall risk.
For hot flashes, the best trial evidence suggests any effect is modest and takes months to appear [9]. If you have a thyroid condition, check with your doctor before taking soy isoflavone supplements [17]. Women with a history of breast cancer should also ask their doctor first, because the evidence in that group is limited [16]. If you are pregnant or breastfeeding, ask a doctor before taking soy supplements.
See the full soy topic page for doses, side effects and the caveats.
Go deeper
- Soy — Soy protein lowers LDL cholesterol by a small amount, about 5 mg/dL in pooled trials, but the LDL effect was not statistically significant in one analysis of p…
References
- A Meta-Analysis of 46 Studies Identified by the FDA Demonstrates that Soy Protein Decreases Circulating LDL and Total Cholesterol Concentrations in Adults.. J Nutr, 2019.
- Soya products and serum lipids: a meta-analysis of randomised controlled trials.. Br J Nutr, 2015.
- The effects of isolated soy protein, isolated soy isoflavones and soy protein containing isoflavones on serum lipids in postmenopausal women: A systematic review and meta-analysis.. Crit Rev Food Sci Nutr, 2020.
- Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.. JAMA, 2016.
- Phytoestrogens for menopausal vasomotor symptoms.. Cochrane Database Syst Rev, 2013.
- Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.. Menopause, 2014.
- Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis.. Eur J Epidemiol, 2020.
- Cumulative Meta-Analysis of the Soy Effect Over Time.. J Am Heart Assoc, 2019.
- Quantitative efficacy of soy isoflavones on menopausal hot flashes.. Br J Clin Pharmacol, 2015.
- Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial.. Menopause, 2012.
- Effects of Soy Protein Containing of Isoflavones and Isoflavones Extract on Plasma Lipid Profile in Postmenopausal Women as a Potential Prevention Factor in Cardiovascular Diseases: Systematic Review and Meta-Analysis of Randomized Controlled Trials.. Nutrients, 2021.
- Assessing the combined effects of Black Cohosh, Soy Isoflavones, and SDG Lignans on menopausal symptoms: a randomized, double-blind, placebo-controlled clinical trial.. Eur J Nutr, 2025.
- Efficacy and Safety of a Standardized Soy and Hop Extract on Menopausal Symptoms: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. J Altern Complement Med, 2021.
- The effect of a randomized 12-week soy drink intervention on everyday mood in postmenopausal women.. Menopause, 2019.
- The effect of soy isoflavones given to women in the climacteric period on menopausal symptoms and quality of life: Systematic review and meta-analysis of randomized controlled trials.. Explore (NY), 2024.
- Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis.. Eur J Nutr, 2019.
- The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study.. J Clin Endocrinol Metab, 2011.
- Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers.. Drug Res (Stuttg), 2016.
- Interference or Noninterference Between Soy and Levothyroxine: That Is the Question. A Narrative Review of Literature.. Endocr Pract, 2023.